Labat’s acquisition of 75% of Leaf Botanicals’ operations in South Africa for ZAR 11.25 million

Lead party: Labat Africa Limited (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Leaf Botanicals (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Preference Shares (Equity) · Deal amount:…


Lead party: Labat Africa Limited (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Leaf Botanicals (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa

Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Preference Shares (Equity) · Deal amount: US$801,368 · Equity stake: 0.75% · Implied EV: US$1.1m

Lead investor/buyer: Labat Africa Limited · Investors/buyers: Labat Africa Limited

Legal advisers: not identified in the source record.

Source: announced 19 May 2021. Original announcement: labat.co.za.